VBIO

Valion Bio, Inc.

Insider activity for last month from 08/25 to 09/25. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingSep 24, 2026Most recent Form 4
Total buying$00 buys
Total selling$00 sells
Net open-market+$02 insiders
Open-market mix
Buy vs sell distribution by transaction count
0 transactions

Insider activity report

Monthly purchases, sales and code-A awards
Buys Sells Awards / grants (A)
530-3-5transactionsAugSep 2026 code-A awards / grants: 1 transactions1Sep

Code A includes awards, grants and other acquisitions; these are not open-market buys.

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (2)
Aug 2026Sep 2026
2distinct insiders in 2 months
Top insiders
By absolute net value across the selected period
2 insiders
  • WG
    Wolf Lisa GCOO, CFO · rank 1 · 0 buys · 0 sells · 0 awards (A)
    -$4last 09/24/2026
  • ZD
    Zikria DeanIC · rank 2 · 0 buys · 0 sells · 1 awards (A)
    +$0last 09/24/2026
Recent filing activity
Most recent 4 transactions · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale-
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
4transactionstxns
  • M · Option exercise · dominant2 · 50%
  • A · Grants / awards1 · 25%
  • F · Tax withholding1 · 25%

Activity by reported role

A joint filing can contribute to multiple roles
7transactionstxns
  • Chief financial officer · dominant3 · 43%
  • COO3 · 43%
  • IC1 · 14%

Reported Holdings After

Separated by insider, security, and ownership type

Wolf Lisa GCommon Stock · Direct
2927Sep 18, 2026Sep 18, 2026
29Sep 18, 2026
Wolf Lisa GRestricted Stock Units · Direct
1919Sep 18, 2026Sep 18, 2026
19Sep 18, 2026
Zikria DeanRestricted Stock Units · Direct
50.0k50.0kSep 22, 2026Sep 22, 2026
50,000Sep 22, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
1 active days
Aug 25 → Sep 25
LessMore

Filing-only signals

Deterministic matches in the selected period

No filing-only signal badges matched this period.

VBIO transaction history

Filters apply within this company and selected period by default
Reset

Latest insider transactions

Form 4 filings from last month. Click any column to sort; click it again to flip the order.

Newest company filings
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#229144VBIOZikria Dean
IC
grant50.0k$0A09/2409/22
#229143VBIOWolf Lisa G
COOCFO
exercise4$0M09/2409/18
#229142VBIOWolf Lisa G
COOCFO
withholding2-$424F09/2409/18
#229141VBIOWolf Lisa G
COOCFO
exercise4—M09/2409/18

Valion Bio, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Valion Bio, Inc.?

Zikria Dean, Wolf Lisa G.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

No code-P purchases or code-S sales were reported in the selected period.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.